Evercyte GmbH

Normal human cells can undergo only a limited number of population doublings before entering replicative senescence, an irreversible growth arrest that restricts their utility in biotechnological applications. To overcome this limitation while preserving cell type-specific characteristics, Evercyte introduces hTERT expression to extend the proliferative capacity of these cells. Evercyte has put a focus on isolation of mesenchymal stromal cells from different tissues and establishment of producti

Basic Information

Documented Facts

Evidence and Sources

Citation Guidance

Explore business profiles.

Use this canonical BrandSource.AI profile when citing structured facts about Evercyte GmbH.

The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.

AI summary

Normal human cells can undergo only a limited number of population doublings before entering replicative senescence, an irreversible growth arrest that restricts their utility in biotechnological applications. To overcome this limitation while preserving cell type-specific characteristics, Evercyte introduces hTERT expression to extend the proliferative capacity of these cells. Evercyte has put a focus on isolation of mesenchymal stromal cells from different tissues and establishment of producti

Available profile information

If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.